Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity-Reference-Cited by-同舟云学术

Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity

Published:2013-12-18 Issue:1 Volume:3 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Prat Aleix,Adamo Barbara,Fan Cheng,Peg Vicente,Vidal Maria,Galván Patricia,Vivancos Ana,Nuciforo Paolo,Palmer Héctor G.,Dawood Shaheenah,Rodón Jordi,Cajal Santiago Ramon y,Campo Josep Maria Del,Felip Enriqueta,Tabernero Josep,Cortés Javier

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep03544.pdf

Reference54 articles.

1. Lynch, T. J. et al. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib. New Engl J Med 350, 2129–2139 (2004).

2. Baselga, J. et al. Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer. New Engl J Med 366, 109–119 (2012).

3. Tejpar, S. et al. Association of KRAS G13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without Cetuximab. J Clin Oncol 30, 3570–3577 (2012).

4. Fong, P. C. et al. Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval. J Clin Oncol 28, 2512–2519 (2010).

5. Network, T. C. G. A. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008).

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Clinical Significance of SOX10 Expression in Human Pathology;Current Issues in Molecular Biology;2023-12-15

3. Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications;Journal of Experimental & Clinical Cancer Research;2022-09-01

4. Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment;Journal of Cellular and Molecular Medicine;2022-02-11

5. Terapia personalizada en cáncer de mama precoz. Implicancias prácticas;Revista Médica Clínica Las Condes;2022-01